Infection Control And Biosafety Management Of Breast Biopsy Needle Repositioning Procedures

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

Infection control is always a core issue of medical safety during breast biopsy. The repositioning procedure of the breast biopsy needle, as a crucial step connecting two sampling procedures, can easily become a potential risk point for pathogen transmission if not handled properly. This article will systematically explore infection control and biosafety management strategies in the repositioning procedure from three dimensions: microbiology, instrument handling, and operational procedures.

The risk of microbial transmission during the repositioning procedure mainly comes from two aspects: first, residual tissue fragments and blood in the needle groove become a bacterial culture medium; second, the repositioning action itself may carry contaminants from the needle tip back to the subcutaneous tissue or spread them into the environment. Studies have shown that Staphylococcus epidermidis, Staphylococcus aureus, and even Mycobacterium tuberculosis can be detected in the biopsy needle groove if it is not cleaned in a timely manner. For bloodborne pathogens such as HIV and HBV, aerosols or splashes of liquid during the repositioning process also pose an occupational exposure risk.

For reusable metal biopsy needles (stainless steel or titanium alloy), the pre- and post-repositioning procedures are crucial. Before repositioning, if there is significant tissue blockage in the needle groove, it should be flushed with sterile saline. Sharp instruments must never be used to dig, as this may damage the needle tip or alter the shape of the cutting groove. After repositioning, immediate pretreatment is necessary: ​​immerse the needle body in an enzyme-containing cleaning solution to soften coagulated proteins. Then proceed to the cleaning and disinfection stage: first, manually scrub the gaps between the needle hub and the repositioning mechanism, then use ultrasonic cleaning to remove microscopic residues, and finally autoclave (134°C, 4 minutes) or low-temperature plasma sterilization.

Special attention should be paid to the internal channels of the repositioning mechanism (such as the spring chamber and locking groove), which are difficult to clean. These areas come into contact with contaminants during repositioning but are difficult for the cleaning solution to reach. Therefore, it is recommended to use biopsy needles with a "self-cleaning" design, or to use a dedicated flushing connector to inject the cleaning solution directly into the repositioning cavity during cleaning.

While disposable polymer biopsy needles do not require sterilization and reuse, strict aseptic techniques must still be followed during repositioning. Because polymer surfaces readily attract microorganisms due to electrostatic attraction, contact between the needle and non-sterile surfaces (such as sheets or the outside of gloves) should be avoided during repositioning. If needle tip contamination occurs during repositioning, even if the needle does not fire, it should be considered a contaminated instrument and replaced immediately.

Regarding the operating environment, repositioning should ideally be performed within a sterile area. It is recommended to perform repositioning within the draped area, avoiding crossing sterile zones. When assisting with repositioning, nurses should wear double gloves and rapidly disinfect the outer glove after each repositioning. For patients with known infectious diseases, repositioning procedures should preferably be performed in a negative pressure operating room or isolation room.

Biosafety measures also include training for operators. Healthcare personnel must master the "non-contact repositioning technique": holding the needle hub rather than the needle body for repositioning to reduce contact between fingers and potentially contaminated areas. Simultaneously, the use of sharps containers should be standardized-repositioned biopsy needles, whether reused or not, must not be bent, broken, or recapped by hand.

From a monitoring perspective, medical institutions should establish an active surveillance system for biopsy needle-related infections. Special attention should be paid to local redness, swelling, suppuration, or fever symptoms appearing within 48 hours after the repositioning procedure. Once a cluster of infections is discovered, the repositioning procedure should be traced immediately to investigate any common violations.

It is noteworthy that novel antibacterial coating technologies are being applied to biopsy needle manufacturing. For example, silver ion coatings and quaternary ammonium salt modified polymers can effectively inhibit bacterial adhesion and reduce the bioburden during the repositioning process. Although these products are more expensive, they have significant clinical value for immunocompromised patients or high-risk procedures.

Finally, medical waste management cannot be ignored. Contaminants generated during the repositioning procedure (such as blood-stained cotton balls and discarded needle cores) should be placed in puncture-proof and leak-proof containers and disposed of according to the "Regulations on the Management of Medical Waste." In particular, waste liquids containing chemical sterilizing agents such as formaldehyde and glutaraldehyde must be collected and treated separately.

In conclusion, the repositioning procedure for breast biopsy needles is not merely a mechanical action, but a crucial link in the infection control chain. Only by adhering to aseptic techniques throughout the entire process before, during, and after repositioning can the risk of iatrogenic infection be minimized, ensuring the safety of both doctors and patients.